Preclinical and Clinical Advances to Overcome Hypoxia in Glioblastoma Multiforme

The authors discuss the recent preclinical and clinical approaches that aim at targeting tumor hypoxia to enhance the response of glioblastoma multiforme to conventional therapies along with their results and limitations upon clinical translation.